New m-calpain substrate-based azapeptide inhibitors

Area of Science:

• Biochemistry
• Enzymology
• Medicinal Chemistry

Background:

• Calpains are crucial intracellular cysteine proteases involved in various physiological processes.
• Dysregulation of calpain activity is implicated in numerous diseases, highlighting the need for effective inhibitors.
• Understanding calpain function requires precise tools for analyzing enzyme interactions.

Purpose of the Study:

• To synthesize and characterize novel azapeptide analogs derived from an m-calpain substrate.
• To investigate the structure-activity relationships of these azapeptides concerning calpain inhibition.
• To identify key amino acid positions critical for calpain inhibitory activity.

Main Methods:

• Synthesis of azapeptide analogs with modifications at P1, P3, P2, P'1, and P'2 positions.
• Truncation of N-terminal or C-terminal ends of the peptide sequences.
• Solution conformation and characterization of the synthesized azapeptides.
• Assessment of varying levels of calpain inhibition by the novel compounds.

Main Results:

• The synthesized azapeptides exhibit varying degrees of calpain inhibition.
• Amino acid identity between P4 and P'5 positions is critical for inhibitory efficacy.
• Modifications at the P3 position (Pro) are tolerated, while other changes significantly impact activity.
• The novel azapeptide analogs serve as valuable tools for studying enzyme-substrate interactions.

Conclusions:

• Azapeptide analogs offer a promising avenue for developing specific calpain inhibitors.
• The study elucidates the importance of specific amino acid residues in calpain-azapeptide interactions.
• These compounds can facilitate further research into calpain's role in disease pathogenesis.